"Na MRI zalo\u017Een\u00E9 3D pl\u00E1nov\u00E1n\u00ED brachyradioterapie karcinom\u016F d\u011Blo\u017En\u00EDho hrdla - na\u0161e zku\u0161enosti s pou\u017Eit\u00EDm uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT" . . . "[8785CB1858A0]" . "11140" . "CZ - \u010Cesk\u00E1 republika" . "Na MRI zalo\u017Een\u00E9 3D pl\u00E1nov\u00E1n\u00ED brachyradioterapie karcinom\u016F d\u011Blo\u017En\u00EDho hrdla - na\u0161e zku\u0161enosti s pou\u017Eit\u00EDm uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT"@cs . "1" . "MRI based 3D brachytherapy planning of the cervical cancer - our experiences with the use of the uterovaginal Vienna Ring MR CT applicator"@en . "7"^^ . . "6"^^ . . . "Na MRI zalo\u017Een\u00E9 3D pl\u00E1nov\u00E1n\u00ED brachyradioterapie karcinom\u016F d\u011Blo\u017En\u00EDho hrdla - na\u0161e zku\u0161enosti s pou\u017Eit\u00EDm uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT"@cs . "Uterovaginal brachytherapy planning is conventionally based on the use of two orthogonal Xray projections. Currently, there is a large development of 3D brachytherapy planning based on the fusion of CT and MRI, which takes into account the extent of the tumor and the location of organs at risk. In this work, we evaluated the dosimetric data and first clinical results in patients with inoperable cervical cancer using MRI/ CT compatible applicator enabling 3D planning. Between June 2012 and March 2013, we performed 52 uterovaginal applications in 13 patients with inoperable cervical cancer using Vienna Ring MR CT applicator. Planning was carried out by the fusion of MRI and CT. Target volumes and organs at risk delineation were carried out on the basis of GEC ESTRO and ABS recommendations as well as doses report-ing."@en . "Vojt\u00ED\u0161ek, Radovan" . "MRI based 3D brachytherapy planning of the cervical cancer - our experiences with the use of the uterovaginal Vienna Ring MR CT applicator"@en . . . "Ferda, Ji\u0159\u00ED" . . "http://www.linkos.cz/files/klinicka-onkologie/183/4389.pdf" . . "0862-495X" . "3"^^ . . "F\u00EDnek, Jind\u0159ich" . "Ciprov\u00E1, Radka" . . "\u010Cechov\u00E1, Daniela" . . "RIV/00216208:11140/14:10218376" . "Na MRI zalo\u017Een\u00E9 3D pl\u00E1nov\u00E1n\u00ED brachyradioterapie karcinom\u016F d\u011Blo\u017En\u00EDho hrdla - na\u0161e zku\u0161enosti s pou\u017Eit\u00EDm uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT" . "Klinick\u00E1 onkologie" . . "uterovaginal applicator; magnetic resonance imaging; radiotherapy planning; brachytherapy; cancer of the cervix"@en . "Pl\u00E1nov\u00E1n\u00ED uterovagin\u00E1ln\u00ED brachyterapie je konven\u010Dn\u011B zalo\u017Eeno na pou\u017Eit\u00ED dvou ortogon\u00E1ln\u00EDch rentgenov\u00FDch sn\u00EDmk\u016F. V sou\u010Dasn\u00E9 dob\u011B doch\u00E1z\u00ED k rozvoji 3D pl\u00E1nov\u00E1n\u00ED brachyterapie zalo\u017Een\u00E9ho na f\u00FAzi CT a MRI vy\u0161et\u0159en\u00ED, kter\u00E9 bere do \u00FAvahy individu\u00E1ln\u00ED rozsah tumoru a ulo\u017Een\u00ED kritick\u00FDch org\u00E1n\u016F. V t\u00E9to pr\u00E1ci hodnot\u00EDme dozimetrick\u00E9 \u00FAdaje a prvn\u00ED klinick\u00E9 v\u00FDsledky u pacientek s neoperovan\u00FDm cervik\u00E1ln\u00EDm karcinomem p\u0159i pou\u017Eit\u00ED MRI/ CT kompatibiln\u00EDho aplik\u00E1toru umo\u017E\u0148uj\u00EDc\u00EDho 3D pl\u00E1nov\u00E1n\u00ED. Soubor pacient\u016F a metody: V obdob\u00ED 6/ 2012- 3/ 2013 jsme provedli 52 uterovagin\u00E1ln\u00EDch aplikac\u00ED u 13 pacientek s inoperabiln\u00EDm cervik\u00E1ln\u00EDm karcinomem pomoc\u00ED uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT. Pl\u00E1nov\u00E1n\u00ED prob\u011Bhlo podle f\u00FAze CT a MRI vy\u0161et\u0159en\u00ED p\u00E1nve. Konturace c\u00EDlov\u00FDch objem\u016F a kritick\u00FDch struktur byla prov\u00E1d\u011Bna na z\u00E1klad\u011B doporu\u010Den\u00ED GEC- ESTRO a ABS, stejn\u011B tak jako vykazov\u00E1n\u00ED d\u00E1vek." . . "27" . "31319" . . . "Pl\u00E1nov\u00E1n\u00ED uterovagin\u00E1ln\u00ED brachyterapie je konven\u010Dn\u011B zalo\u017Eeno na pou\u017Eit\u00ED dvou ortogon\u00E1ln\u00EDch rentgenov\u00FDch sn\u00EDmk\u016F. V sou\u010Dasn\u00E9 dob\u011B doch\u00E1z\u00ED k rozvoji 3D pl\u00E1nov\u00E1n\u00ED brachyterapie zalo\u017Een\u00E9ho na f\u00FAzi CT a MRI vy\u0161et\u0159en\u00ED, kter\u00E9 bere do \u00FAvahy individu\u00E1ln\u00ED rozsah tumoru a ulo\u017Een\u00ED kritick\u00FDch org\u00E1n\u016F. V t\u00E9to pr\u00E1ci hodnot\u00EDme dozimetrick\u00E9 \u00FAdaje a prvn\u00ED klinick\u00E9 v\u00FDsledky u pacientek s neoperovan\u00FDm cervik\u00E1ln\u00EDm karcinomem p\u0159i pou\u017Eit\u00ED MRI/ CT kompatibiln\u00EDho aplik\u00E1toru umo\u017E\u0148uj\u00EDc\u00EDho 3D pl\u00E1nov\u00E1n\u00ED. Soubor pacient\u016F a metody: V obdob\u00ED 6/ 2012- 3/ 2013 jsme provedli 52 uterovagin\u00E1ln\u00EDch aplikac\u00ED u 13 pacientek s inoperabiln\u00EDm cervik\u00E1ln\u00EDm karcinomem pomoc\u00ED uterovagin\u00E1ln\u00EDho aplik\u00E1toru Vienna Ring MR- CT. Pl\u00E1nov\u00E1n\u00ED prob\u011Bhlo podle f\u00FAze CT a MRI vy\u0161et\u0159en\u00ED p\u00E1nve. Konturace c\u00EDlov\u00FDch objem\u016F a kritick\u00FDch struktur byla prov\u00E1d\u011Bna na z\u00E1klad\u011B doporu\u010Den\u00ED GEC- ESTRO a ABS, stejn\u011B tak jako vykazov\u00E1n\u00ED d\u00E1vek."@cs . "RIV/00216208:11140/14:10218376!RIV15-MSM-11140___" . . "Mouryc, Franti\u0161ek" . . "I" .